, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
, Ahmad Ameri1 and Mona Malekzadeh2 (1) Department of Clinical Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Shahid Madani Street, Tehran, Iran (2) Department of Radiotherapy and…
Malignant Nonmalignant Primary endoluminal carcinoma Lymphadenopathy Bronchogenic Sarcoidosis Adenoid cystic Infectious (i.e., tuberculosis) Mucoepidermoid Vascular Carcinoid Sling Metastatic carcinoma to the airway Cartilage Bronchogenic Relapsing polychondritis Renal cell Granulation tissue…
Acute clinical-histopathologic patterns Typical drugs Diffuse alveolar damage (DAD/ARDS) Bleomycin, busulfan, cyclophosphamide, mitomycin, amiodarone Diffuse alveolar hemorrhage (DAH) Anticoagulants, amphotericin B, cytarabine (ara-C), penicillamine, cyclophosphamide Pulmonary edema (PE) Blood transfusions,…
